Stocks making the biggest moves after hours: Novo Nordisk, Interactive Brokers, CSX and more
Check out the companies making headlines in after-hours trading. CSX Corporation — Shares of the railroad jumped 2% on the back of its strong quarterly results. CSX reported adjusted earnings of 44 cents per share on revenue of $3.59 billion for its third quarter, just beating analysts’ earnings expectations of 42 cents per share on $3.58 billion in revenue, per LSEG. Declining coal prices and merchandise volume led to slightly lower revenue during the period. Interactive Brokers Group — The stock fell nearly 3% despite reporting a beat on top and bottom lines. The company’s adjusted earnings of 57 cents per share exceeded analysts’ forecast of 54 cents per share, according to LSEG. Its revenue of $1.61 billion also came out higher than the $1.52 billion analysts had called for. The global electronic broker reported a 21% jump in net interest income to $967 million on stronger securities lending, higher average customer margin loans and credit balances. Oracle — Shares of the cloud infrastructure provider fell 2.4% in after-hours trading after it provided analysts its long-term financial outlook . Oracle expects its revenue will rise at a 31% compound annual growth rate over the next five years. Oracle, which rose 3% on Thursday, said during its AI World conference in Las Vegas that its core database and data platform business will grow and also announced a cloud computing deal with Meta. Bank OZK — Shares of the regional bank fell 3% after disappointing third-quarter earnings. Bank OZK earned $1.59 per share, short of the $1.66 per share expected from analysts polled by FactSet. The move added to Bank OZK’s nearly 7% decline during Thursday’s trading session, which saw shares of several financial stocks decline amid worries about bad loans . Novo Nordisk , Eli Lilly — Shares of obesity drugmakers were lower in extended trading following comments from President Donald Trump during a briefing on fertility treatments . Trump suggested that the cost of obesity drugs would be “much lower,” but Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said the price of GLP-1 medications had not been negotiated by the administration yet. Shares of Novo Nordisk, the maker of Wegovy and Ozempic, fell 3%, while Eli Lilly, which makes Mounjaro and Zepbound, fell 2%. — Christina Cheddar Berk contributed to this report.
